These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10853539)

  • 1. Consumer perceptions of risk and required cost savings for generic prescription drugs.
    Ganther JM; Kreling DH
    J Am Pharm Assoc (Wash); 2000; 40(3):378-83. PubMed ID: 10853539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.
    Haas JS; Phillips KA; Gerstenberger EP; Seger AC
    Ann Intern Med; 2005 Jun; 142(11):891-7. PubMed ID: 15941695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing consumer purchasing patterns of generic versus brand name over-the-counter drugs.
    Kohli E; Buller A
    South Med J; 2013 Feb; 106(2):155-60. PubMed ID: 23380752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey.
    Kesselheim AS; Gagne JJ; Franklin JM; Eddings W; Fulchino LA; Avorn J; Campbell EG
    J Gen Intern Med; 2016 Jun; 31(6):609-14. PubMed ID: 26883524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summaries for patients. Potential savings with substitution of generic drugs for brand-name drugs.
    Ann Intern Med; 2005 Jun; 142(11):I30. PubMed ID: 15941691
    [No Abstract]   [Full Text] [Related]  

  • 6. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
    Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
    Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perception of generic prescription drugs and utilization of generic drug discount programs.
    Omojasola A; Hernandez M; Sansgiry S; Jones L
    Ethn Dis; 2012; 22(4):479-85. PubMed ID: 23140080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
    Spence MM; Nguyen LM; Hui RL; Chan J
    Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential savings from generic prescribing and generic substitution in South Africa.
    Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS
    Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge, Experience, and Perceptions of Generic Drugs among Middle-Aged Adults and their Willingness-to-Pay: A Nationwide Online Survey in Japan.
    Ito Y; Hara K; Sato H; Tomio J
    Tohoku J Exp Med; 2021 Sep; 255(1):9-17. PubMed ID: 34497247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.
    Fischer MA; Avorn J
    Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):207-14. PubMed ID: 15255087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intention of purchasing generic prescription drugs on the part of consumers in Asturias, Spain].
    González Hernando S; González Mieres C; Díaz Martín AM
    Rev Esp Salud Publica; 2003; 77(6):691-9. PubMed ID: 14965061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice of generic versus brand-name antidepressants in a regulated prescription drug market: evidence from Taiwan.
    Liu YM; Ou HT; Yang YK
    J Ment Health Policy Econ; 2014 Dec; 17(4):163-72. PubMed ID: 25599280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bib Pharma Monopoly: Why Consumers Keep Landing on "Park Place" and How the Game is Rigged.
    Levy MS
    Am Univ Law Rev; 2016; 66(1):247-303. PubMed ID: 28225582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of prescription of generic drugs for cost containment in pharmaceutics. Analysis in the Community of Navarra].
    Ansa Erice I; Agudo Pascual C; Artazcoz Sanz M; Carnicero Giménez de Azcárate J
    Aten Primaria; 1996 Apr; 17(6):411-4. PubMed ID: 8672647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Utilization of generic drugs in Spain and Catalonia: possibilities of savings].
    Torralba Guirao M; Gilabert Perramon A; Peláez de Loño J; Faixedas Brunsoms MT
    Aten Primaria; 2000 Sep; 26(4):210-5. PubMed ID: 11100580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents.
    Sacks CA; Lee CC; Kesselheim AS; Avorn J
    JAMA; 2018 Aug; 320(7):650-656. PubMed ID: 30140875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generic drug prescriptions following hospital discharge: a prospective study in France.
    Chu C; Rudant E; Bonvalet M; Agostini H; Cavalié P; Bonhomme-Faivre L; Frenkiel J; Taillandier J; Boissonnas A; Vittecoq D; Wyplosz B
    Eur J Intern Med; 2011 Oct; 22(5):e45-9. PubMed ID: 21925042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saving money on your prescription drugs.
    Johns Hopkins Med Lett Health After 50; 2010 Jan; 21(11):4-5. PubMed ID: 20336846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.